|
|
1:1 meetings facilitated for you
Using our propriatary "Contact" system, start pre-arranging your 1:1 partnering meetings with pharmas and biotechs now, before your competitiors do!
or call +44 (0) 207 827 5997
|
|
|
|
| |
|
| |
|
Innovation and opportunity for pharma, biotechs,healthcare and investors
|
|
|
| |
|
In under 2 weeks time, the 9th annual World Vaccine Congress Washington opens its doors to over 375 of the World’s leading strategic and scientific minds. If you haven`t already confirmed your place at North America’s largest Vaccine industry congress then be sure to secure your place soon as the congress is fast approaching sell out capacity.
Not only is the 2009 congress shaping up to be the biggest yet, in terms of delegate attendance and exhibition, it also boasts an attendance of unmatchable seniority. Some statistics that may help you with your decision making:
- Biotech 26%
- Pharma 24%
- Government 9%
- NGO 7%
- CRO 11%
- CMO 6%
- Equipment Manufacturer 5%
- Consultant 4%
- Venture Capital 3%
- Academic 2%
- Drug Delivery 2%
- Press 1%
>> Download the brochure now
>> Register now
- Chairman/President/CxO 20%
- Managing Director/General Manager 4%
- SVP/EVP/VP 13%
- Department Chief/Head/Director 20%
- Senior Director/Manager 6%
- Deputy/Assistant Director/Manager 4%
- Project/Program Director/Manager 19%
- Managing Partner/Partner 3%
- Medical Director/Lead 2%
- Professor/Scientist 6%
- Principal/Senior Consultant/Analyst 3%
“The event was an outstanding learning and networking opportunity for me and my institution”
Cindy Gustafson, CFO, Seattle Biomedical Research Institute
|
|
|
 |
NETWORK WITH 120+ SPEAKERS INCLUDING:
|
MARGIE MCGLYNN
President,
Merck Vaccines
& Infectious Diseases,
Merck & Co.
|
|
|
| |
DR BRUCE GELLIN
Director, National Vaccine Programme, US Department of Health and Human Services
DR REINER LAUS
Chief Executive Officer, BN Immuno
Therapeutics
DR MONIQUE MANSOURA
Director of Policy, Planning and Requirements, BARDA, ASPR, US Department of Health and Human Services
DAVID WRIGHT
Chief Executive Officer, PharmaAthene
DR ALAN SHAW
Chief Executive Officer, Vaxinnate
DR JOHN SHIVER
Vice President, Worldwide Basic Research, Head of Vaccines, Merck Research Laboratories
|
|
KAREN MIDTHUN
Deputy Director, CBER, FDA
WILLAIM ENRIGHT
Chief Executive Officer, Vaxin
DR MARVIN KALT
Director, Division of Extramural Activities, NIAID, NIH
DR CARL DIEFFENBACH
Director, Division of AIDS, National Institute of Allergy and Infectious Diseases
DR RAAFAT FAHIM
Chief Executive Officer, Nabi Pharmaceuticals
DR HARTMUT EHRLICH
Vice President, Global Reseach and Development, Baxter Bioscience
|
|
DR NEIL BERINSTEIN
Head Cancer Vaccine Program, sanofi pasteur
DR RAHUL SINGHVI
Chief Executive Officer, Novavax
DR MICHAEL KURILLA
Director, Office of Biodefense Research Activities in the Division of Microbiology and Infectious Diseases, Associate Director for Biodefense Product Development, NIAID, NH, US Department of Health and Human Services
DR BEATRICE DE VOS
Vice President, Global Scientific and Medical Affairs, sanofi pasteur
DR ANTHONY FORD-HUTCHINSON
Senior Vice President and Franchise Head, Vaccines and Infectious Diseases, Merck Research Laboratories
|
|
|
| |
|
|
exhibitors
 |
|
|
|
|
|
